A woman who used her life savings to have vaginal mesh removed in the United States said she could no longer wait for surgery in Northern Ireland after passing blood and debris. Sylvia Vickery, 61 ...
NKT-3447 is under clinical development by NiKang Therapeutics and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase I drugs for Endometrial Cancer have an 81% phase ...
NKT-3447 is under clinical development by NiKang Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 70% phase transition success rate ...
Please register yourself for unlimited free access. Redirecting to register page ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback